发明名称 AIDING ASSESSMENT OF PROGNOSIS IN INFLAMMATORY DISEASE
摘要 Some embodiments are directed to a method of collecting information useful in predicting clinical outcome in a subject, the method including providing a sample from said subject, and determining the level of octameric PTX3 in said sample, wherein determining the level of octameric PTX3 includes measuring the total amount of PTX3 present, and measuring the amount of octameric PTX3 present, and calculating the proportion of total PTX3 which is present as octamer, wherein if the proportion of octameric PTX3 is greater than 50%, the subject is identified as a likely non-survivor. Some embodiments are also directed to a method of collecting information useful in predicting clinical outcome in a subject, the method including providing a sample from said subject, and determining the level of octameric PTX3 in said sample, wherein an elevated level of octameric PTX3 compared to a reference level indicates a reduced likelihood of survival.
申请公布号 US2016123994(A1) 申请公布日期 2016.05.05
申请号 US201414893341 申请日期 2014.05.20
申请人 KING'S COLLEGE LONDON 发明人 MAYR Manuel;CUELLO Friederike
分类号 G01N33/68 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method of collecting information useful in predicting clinical outcome in a subject, the method comprising providing a sample from said subject, and determining the level of octameric PTX3 in said sample, wherein determining the level of octameric PTX3 comprises measuring the total amount of PTX3 present, and measuring the amount of octameric PTX3 present, and calculating the proportion of total PTX3 which is present as octamer, wherein if the proportion of octameric PTX3 is greater than 50%, the subject is identified as a likely non-survivor.
地址 London GB